Page 714 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 714

692   PART IV    Specific Malignancies in the Small Animal Patient



          TABLE 33.1     World Health Organization Classification System for Canine Lymphoma
                                                                               PERCENTAGE
  VetBooks.ir  Category                                Seelig et al 96     Vezzali et al 98    University of Wisconsin

                                                       (n = 3 data sets)
                                                                                               (n = 122)
                                                                           (n = 123)
            B-Cell Neoplasms                           69                  78.9                59.0
            Precursor B lymphoblastic leukemia/lymphoma a  —                2.4                8.2
            B-cell chronic lymphocytic leukemia/small lymphocytic lym-  —   2.4                0.8
              phoma
            Lymphocytic lymphoma—intermediate type     —                    0.8                —
            Lymphoplasmacytic lymphoma                 —                    3.3                0.8
            Mantle cell lymphoma                       2                    1.6                —
            Follicular center cell lymphomas           —                    2.4                —
            Marginal zone lymphoma (splenic, nodal, mucosa-associated   8   3.3                2.5
              lymphoid tissue)
            Plasma cell myeloma/plasmacytoma           —                   16.3                9.8
            Diffuse large cell lymphoma                52                  33.3                24.6
            T-cell–rich, B-cell lymphoma               —                    0.8                —
            Large cell immunoblastic lymphoma          —                   10.6                10.7
            Mediastinal (thymic) large B-cell lymphoma  —                   0.8                —
            Burkitt’s lymphoma/leukemia                —                    0.8                1.6
            Other B cell                               8 d                 —                   —
            T-Cell and Natural Killer (NK ) Cell Lymphomas  31             21.1                41.0
                               b
            Precursor T lymphoblastic lymphoma/leukemia a  3                6.5                9.8
            T-cell chronic lymphocytic leukemia (CLL)  —                    3.3                0.8
            Intestinal T-cell lymphoma                 —                    4.1                4.1
            Mycosis fungoides/Sézary syndrome          —                    1.6                11.5
            Cutaneous nonepitheliotropic lymphoma      —                    3.3                —
            Anaplastic large cell lymphoma             —                   —                   0.8
            Peripheral T-cell lymphoma-not otherwise specified  15          2.4                13.1 c
            T-zone lymphoma                            4
            Other T cell                               7 d                 —                   —
            Other                                      3 d
            a Acute leukemias and lymphoblastic lymphomas of both B and T derivation are also classified as lymphoid “precursor neoplasms.”
            b Non-B, non-T lymphomas.
            c Includes T-zone lymphoma in this data set.
            d Other in Seelig include those not otherwise subclassified.



         prognosis. Preliminary results indicate that dogs with indolent   investigators to “translate” among the numerous classification sys-
         lymphoma (e.g., MZL, follicular lymphoma, B- or T-cell small   tems so that clinical trials could be compared in humans. Most
         cell lymphoma, T-cell–rich B-cell lymphoma, and TZL) maintain   of the larger compilations agree that most canine lymphomas are
         normal activity and appetite levels even during advanced stages of   intermediate or high grade. The WF categorizes tumors according
         disease and experience long-term survival even with limited or no   to pattern (diffuse or follicular) and cell type (e.g., small cleaved
         therapy. 90,99–102                                    cell, large cell, immunoblastic), but it does not include informa-
            Other classification systems that have been used include the   tion about the immunophenotype of the tumor. 103  The WF sub-
         National Cancer Institute  Working Formulation (WF) 103  and   types are related to the biology of the tumor and patient survival.
         the updated  Kiel system. 104  The  WF  was developed  to allow   The updated Kiel classification includes the architectural pattern,
   709   710   711   712   713   714   715   716   717   718   719